Glenmark Investigational Site 209 — Detroit, Michigan

Glenmark Investigational Site 209 is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Glenmark Investigational Site 209 has participated in 1 clinical trials.

Therapeutic areas: HER2 Expressing Solid Tumours.

Sponsors: Ichnos Sciences SA.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Glenmark Investigational Site 209?

Glenmark Investigational Site 209 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Glenmark Investigational Site 209 conducted?

Glenmark Investigational Site 209 has 1 clinical trials on record. Their work covers HER2 Expressing Solid Tumours.

Is Glenmark Investigational Site 209 accredited by Crixeo Health?

Glenmark Investigational Site 209 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Glenmark Investigational Site 209?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.